Yield of diagnostic testing in evaluating etiology and end organ effects of pediatric hypertension

FangChao Linda Ding1, Isaac Elias1, Rebecca Wright1

  • 1Department of Pediatrics, University of British Columbia, Vancouver, British Columbia, Canada.

Insights

Secondary hypertension is common in children, even those with risk factors for primary hypertension. Kidney ultrasound, lipid profiles, and echocardiograms are high-yield investigations for diagnosing pediatric hypertension.

Area of Science:

  • Pediatric Nephrology
  • Cardiovascular Health
  • Diagnostic Yield

Background:

  • Current guidelines for pediatric hypertension investigations lack robust evidence, leading to varied clinical practices.
  • Limited data exists on which children benefit most from secondary hypertension workup.

Purpose of the Study:

  • To identify children who may benefit from secondary hypertension evaluation.
  • To determine the diagnostic yield of various investigations for pediatric hypertension.

Main Methods:

  • A retrospective cohort study of 169 children (aged 1-18 years) evaluated for hypertension at a Canadian tertiary pediatric nephrology center.
  • Analysis of completed investigations, abnormal findings, and etiological diagnoses.

Main Results:

  • Secondary hypertension was diagnosed in 72 children, more common than primary hypertension (56 children) across most age groups.
  • Kidney ultrasound showed the highest diagnostic yield (19.8%), with no age-related differences.
  • Echocardiograms identified target-organ effects in 33.3% of hypertensive children; lipid profiles were abnormal in 25.4% of overweight/obese children.

Conclusions:

  • A simplified secondary hypertension workup is recommended for all hypertensive children and adolescents.
  • Key high-yield investigations include kidney ultrasound, lipid profile (for overweight/obese), and echocardiogram.
  • Further testing should be guided by initial results for cost-effective management.
Abstract

Related Concept Videos

Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
27
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
2.1K
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
35
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists01:18

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists

Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
201
Dysrhythmias V: Evaluating Dysrhythmias01:30

Dysrhythmias V: Evaluating Dysrhythmias

Dysrhythmias, also known as arrhythmias, are disturbances in the heart's rhythm that range from benign to life-threatening. A thorough evaluation is crucial for appropriate management and involves a comprehensive medical history, physical examination, and various diagnostic tests.Medical HistorySymptoms: Collect detailed information on palpitations, dizziness, syncope, chest pain, and fatigue. Note their onset, frequency, and triggers.Previous Cardiac Issues: Document any history of heart...
42
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage kidney disease (ESKD). At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate...
36